Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Csaba Polgar

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 19, 2026
In Regard to Facondo et alJean-Michel Hannoun-Levi, Cristina Gutierrez, Vratislav Strnad, et al.
Journal of Breast Cancer|June 30, 2021
In regard to "The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria"Jean Michel Hannoun-Levi, Cristina Gutierrez, Csaba Polgar, et al.
Radiology and Oncology|July 12, 2021
Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective studyKliton Jorgo, Csaba Polgar, Gabor Stelczer, et al.
Clinical and Translational Radiation Oncology|May 17, 2021
<b>E</b>ndocrine therapy with accelerated <b>P</b>artial breast irradiati<b>O</b>n or exclusive ultra-accelerated <b>P</b>artial breast irradiation for women aged ≥ 60 years with <b>E</b>arly-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trialJean-Michel Hannoun-Levi, Emmanuel Chamorey, Rabia Boulahssass, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2022
In Regard to Rahimi et alJean-Michel Hannoun-Levi, José-Luis Guinot, Cristina Gutierrez, et al.
Advanced Drug Delivery Reviews|September 18, 2016
Advancements in brachytherapyKari Tanderup, Cynthia Ménard, Csaba Polgar, et al.
Pathology Oncology Research : POR|March 20, 2019
Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective StudyKliton Jorgo, Csaba Polgar, Tibor Major, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|September 2, 2014
Loose versus stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plansTibor Major, Peter Agoston, Georgina Fröhlich, et al.
International Journal of Radiation Oncology, Biology, Physics|July 17, 2023
Second Conservative Treatment for Local Recurrence Breast Cancer: A GEC-ESTRO Oncological Outcome and Prognostic Factor AnalysisJean-Michel Hannoun-Levi, Jocelyn Gal, Csaba Polgar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2024
Five-year results of the very accelerated partial breast irradiation VAPBI phase I-II GEC-ESTRO trialJose Luis Guinot, Cristina Gutierrez-Miguelez, Norbert Meszaros, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|March 19, 2026
In Regard to Facondo et alJean-Michel Hannoun-Levi, Cristina Gutierrez, Vratislav Strnad, et al.
Journal of Breast Cancer|June 30, 2021
In regard to "The Italian Association of Radiotherapy and Oncology Recommendation for Breast Tumor Recurrence: Grades of Recommendation, Assessment, Development and Evaluation Criteria"Jean Michel Hannoun-Levi, Cristina Gutierrez, Csaba Polgar, et al.
Radiology and Oncology|July 12, 2021
Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective studyKliton Jorgo, Csaba Polgar, Gabor Stelczer, et al.
Clinical and Translational Radiation Oncology|May 17, 2021
<b>E</b>ndocrine therapy with accelerated <b>P</b>artial breast irradiati<b>O</b>n or exclusive ultra-accelerated <b>P</b>artial breast irradiation for women aged ≥ 60 years with <b>E</b>arly-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trialJean-Michel Hannoun-Levi, Emmanuel Chamorey, Rabia Boulahssass, et al.
International Journal of Radiation Oncology, Biology, Physics|May 15, 2022
In Regard to Rahimi et alJean-Michel Hannoun-Levi, José-Luis Guinot, Cristina Gutierrez, et al.
Advanced Drug Delivery Reviews|September 18, 2016
Advancements in brachytherapyKari Tanderup, Cynthia Ménard, Csaba Polgar, et al.
Pathology Oncology Research : POR|March 20, 2019
Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective StudyKliton Jorgo, Csaba Polgar, Tibor Major, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|September 2, 2014
Loose versus stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plansTibor Major, Peter Agoston, Georgina Fröhlich, et al.
International Journal of Radiation Oncology, Biology, Physics|July 17, 2023
Second Conservative Treatment for Local Recurrence Breast Cancer: A GEC-ESTRO Oncological Outcome and Prognostic Factor AnalysisJean-Michel Hannoun-Levi, Jocelyn Gal, Csaba Polgar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 25, 2024
Five-year results of the very accelerated partial breast irradiation VAPBI phase I-II GEC-ESTRO trialJose Luis Guinot, Cristina Gutierrez-Miguelez, Norbert Meszaros, et al.
Pageof 3